Telomere Lengths, Pulmonary Fibrosis and Telomerase (TERT) Mutations
Open accessThe DOI matches its Crossref record; 34 of the 35 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Telomerase is an enzyme that catalyzes the addition of nucleotides on the ends of chromosomes. Rare loss of function mutations in the gene that encodes the protein component of telomerase (TERT) have been described in patients with idiopathic pulmonary fibrosis (IPF). Here we examine the telomere lengths and pulmonary fibrosis phenotype seen in multiple kindreds with heterozygous TERT mutations. METHODS AND FINDINGS: We have identified 134 individuals with heterozygous TERT mutations from 21 unrelated families. Available medical records, surgical lung biopsies and radiographs were evaluated retrospectively. Genomic DNA isolated from circulating leukocytes has been used to measure telomere lengths with a quantitative PCR assay. We find that telomere lengths of TERT mutation carriers decrease in an age-dependent manner and show progressive shortening with successive generations of mutation inheritance. Family members without TERT mutations have a shorter mean telomere length than normal, demonstrating epigenetic inheritance of shortened telomere lengths in the absence of an inherited TERT mutation. Pulmonary fibrosis is an age-dependent phenotype not seen in mutation carriers less than 40 years of age but found in 60% of men 60 years or older; its development is associated with environmental exposures including cigarette smoking. A radiographic CT pattern of usual interstitial pneumonia (UIP), which is consistent with a diagnosis of IPF, is seen in 74% of cases and a pathologic pattern of UIP is seen in 86% of surgical lung biopsies. Pulmonary fibrosis associated with TERT mutations is progressive and lethal with a mean survival of 3 years after diagnosis. Overall, TERT mutation carriers demonstrate reduced life expectancy, with a mean age of death of 58 and 67 years for males and females, respectively. CONCLUSIONS: A subset of pulmonary fibrosis, like dyskeratosis congenita, bone marrow failure, and liver disease, represents a "telomeropathy" caused by germline mutations in telomerase and characterized by short telomere lengths. Family members within kindreds who do not inherit the TERT mutation have shorter telomere lengths than controls, demonstrating epigenetic inheritance of a shortened parental telomere length set-point.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In IPF patients with telomerase mutations, the mean age of onset is 51 years, although IPF can manifest as late as the ninth decade of life70,71.”
From The telomere syndromes (2012) · cites this paper as [70]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In addition, both dyskeratosis congenita and IPF patients are prone to developing haematological malignancies, commonly manifesting as myelodysplasia or acute myeloid leukaemia70,75,76.”
From The telomere syndromes (2012) · cites this paper as [70]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Specific Association of Human Telomerase Activity with Immortal Cells and Cancer
Kim, N. W., Piatyszek, M. A., Prowse, K. R., Harley, C. B., West, M. D., Ho, P. L. C., Coviello, G. M., Wright, W. E., Weinrich, S. L., & Shay, J. W. (1994) · Science · doi:10.1126/science.7605428 · Cited by 7,091 · cited 1×
“hTERT is highly expressed in germ cells, cells with proliferative potential and immortalized cancer cells[3,4,5].”
Background(2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.165.2.ats01 · Cited by 4,196
Identification of a specific telomere terminal transferase activity in tetrahymena extracts
Greider, C. W., & Blackburn, E. H. (1985) · Cell · doi:10.1016/0092-8674(85)90170-9 · Cited by 3,400 · cited 1×
“The human enzyme consists of both a functional RNA (hTR) and a reverse transcriptase protein component (hTERT)[1,2].”
BackgroundThe RNA Component of Human Telomerase
Feng, J., Funk, W. D., Wang, S.-S., Weinrich, S. L., Avilion, A. A., Chiu, C.-P., Adams, R. R., Chang, E., Allsopp, R. C., Yu, J., et al. (1995) · Science · doi:10.1126/science.7544491 · Cited by 2,227 · cited 1×
“The human enzyme consists of both a functional RNA (hTR) and a reverse transcriptase protein component (hTERT)[1,2].”
BackgroundTelomere reduction in human colorectal carcinoma and with ageing
Hastie, N. D., Dempster, M., Dunlop, M. G., Thompson, A. M., Green, D. K., & Allshire, R. C. (1990) · Nature · doi:10.1038/346866a0 · Cited by 1,650 · cited 1×
“Evidence of this is seen by the progressive shortening of telomere lengths of human mononuclear leukocytes with age[6] and several diseases of inherited telomerase dysfunction[7].”
BackgroundTelomere length measurement by a novel monochrome multiplex quantitative PCR method
Cawthon, R. M. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkn1027 · Cited by 1,410 · cited 1×
“Multiplexed quantitative polymerase chain reaction (PCR) determination of telomere lengths were performed on a RotorGene real-time PCR system (Qiagen) as described[21] with 0.”
MethodTelomerase Mutations in Families with Idiopathic Pulmonary Fibrosis
Armanios, M. Y., Chen, J. J.-L., Cogan, J. D., Alder, J. K., Ingersoll, R. G., Markin, C., Lawson, W. E., Xie, M., Vulto, I., Phillips, J. A., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066157 · Cited by 1,357 · cited 1×
“Heterozygous loss-offunction mutations in TERT have been found in up to 15% of kindreds with the familial pulmonary fibrosis[17,18] and in 1–3% of sporadic cases[19,20].”
BackgroundIncidence and Prevalence of Idiopathic Pulmonary Fibrosis
Raghu, G., Weycker, D., Edelsberg, J., Bradford, W. Z., & Oster, G. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200602-163oc · Cited by 1,310 · cited 1×
“However, unlike DKC, IPF is much more common with its prevalence increasing with age to 65 cases per 100,000 for those 75 years or older [16].”
BackgroundSelf-citationHeiss, N. S., Knight, S. W., Vulliamy, T. J., Klauck, S. M., Wiemann, S., Mason, P. J., Poustka, A., & Dokal, I. (1998) · Nature Genetics · doi:10.1038/ng0598-32 · Cited by 976 · cited 1×
“Most DKC patients have mutations in the X-linked DKC1 gene, which encodes dyskerin[8]; fewer patients have mutations in TERC, which encodes hTR[9].”
BackgroundThe RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita
Vulliamy, T., Marrone, A., Goldman, F., Dearlove, A., Bessler, M., Mason, P. J., & Dokal, I. (2001) · Nature · doi:10.1038/35096585 · Cited by 960 · cited 1×
“Most DKC patients have mutations in the X-linked DKC1 gene, which encodes dyskerin[8]; fewer patients have mutations in TERC, which encodes hTR[9].”
Background
Cited by
Items 301–376 of 376
Evaluation of Desmin, α-SMA and hTERT expression in pulmonary fibrosis and lung cancer
Fallahian, F., Moosavi, S. A. J., Mahjoubi, F., Shabani, S., Babaheidarian, P., & Majidzadeh, T. (2018) · Journal of Clinical Intensive Care and Medicine · doi:10.29328/journal.jcicm.1001011 · Cited by 2
“Family members within kindreds who do not inherit the TERT mutation have shorter telomere lengths than controls, demonstrating epigenetic inheritance of a shortened parental telomere length set-point [6].”
BackgroundPlanté-Bordeneuve, T., Haouas, H., Vanderheyde, K., & Froidure, A. (2018) · Acta Clinica Belgica · doi:10.1080/17843286.2018.1545375 · Cited by 2
Khakzad, M., Shahbazi, Z., Naderi, M., & Karimipoor, M. (2023) · Iranian Biomedical Journal · doi:10.52547/ibj.3783 · Cited by 2
“The telomerase structure is comprised of the TERT, RNA component (TERC), and dyskerin protein complex (dyskerin, NOP10, NHP2, and GAR1) [7] .”
BackgroundGenetic aspects of telomere biology disorders
de Tocqueville, S., Morel, H., Ba, I., Revy, P., & Kannengiesser, C. (2025) · Seminars in Hematology · doi:10.1053/j.seminhematol.2026.03.011 · Cited by 2
Schmidt, S. L., & Flaherty, K. R. (2011) · Proceedings of the American Thoracic Society · doi:10.1513/pats.201108-045tt · Cited by 2
“(5) Although our learners are diverse, we insist on educational conformity.”
BackgroundIdiopathic Pulmonary Fibrosis: Phenotypes and Comorbidities
King, C. S., Aryal, S., & Nathan, S. D. (2018) · Respiratory medicine · doi:10.1007/978-3-319-99975-3_11 · Cited by 3
Early‐life liver cirrhosis and variable clinical presentation in telomere disease
Faingelernt, Y., Nassar, R., Ling, G., Kodman, Y., Feuerstein, T., & Yerushalmi, B. (2022) · Acta Paediatrica · doi:10.1111/apa.16539 · Cited by 2
Genetics of Pulmonary Fibrosis
Adams, T. N., & Garcia, C. K. (2018) · Respiratory medicine · doi:10.1007/978-3-319-99975-3_8 · Cited by 3
Self-citationSpagnolo, P., Griese, M., Cocconcelli, E., Bernardinello, N., & Bush, A. (2019) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000000594 · Cited by 2
Babushok, D. V., Hsu, A. P., & Dokal, I. S. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-816768-7.00016-8 · Cited by 2
Alber, A. B., Kwong, G., Gupta, V. K., Dooley, P. E., Patel, J., Bawa, P., Minakin, K., Jones, D. L., Gopal, D., Souza, H., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.01.30.702837 · Cited by 4
Multidisciplinary Approach to Familial Pulmonary Fibrosis
Cheng, K. A., McNulty, R., Nichols, H., Tanimoto, A. A., Vella, M., Crotty, E. J., Carney, J., Soskis, A., McAdams, H. P., & Henry, T. S. (2025) · Radiographics · doi:10.1148/rg.240183 · Cited by 1
Tirelli, C., Rondinone, O., Alfano, F., Cefalo, J., Nalesso, G., Ciracì, M., Salerni, C., Miozzo, M. R., Centanni, S., & Mondoni, M. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15134951 · Cited by 2
“[27–29].”
Miura, Y., Milad, N., Takata, A., & Kanazawa, S. (2025) · Aging · doi:10.18632/aging.206312 · Cited by 6
A Rare TERT Mutation Associated with Idiopathic Pulmonary Fibrosis and COPD in a Chinese Family
Fan, L., Feng, D.-C., Long, J., & Zhang, A. (2025) · Balkan Medical Journal · doi:10.4274/balkanmedj.galenos.2025.2025-6-142 · Cited by 1
“17 However, a subset of patients display an atypical UIP pattern.”
Genetic Familial Interstitial Lung Disease
Fernandez, R. J., & Kropski, J. A. (2025) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2025.07.008 · Cited by 1
Interstitial lung abnormalities: a mechanistic window into early fibrotic lung disease
Selvarajah, B., Buconjic, D., & Hewitt, R. J. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1867568 · Cited by 1
“Reduced telomere length (20, 21), has been consistently linked with IPF and in asymptomatic individuals at high familial risk for pulmonary fibrosis, indicating that telomere attrition may precede overt clinical disease and function as an inherited susceptibility factor (22–24).”
Kradin, R. L. (2012) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2012-0273-sa · Cited by 1
Kokosi, M. A., Renzoni, E. A., & Bonella, F. (2016) · European Respiratory Society eBooks · doi:10.1183/2312508x.10005515 · Cited by 1
Borie, R., Kannengiesser, C., Nathan, N., & Crestani, B. (2016) · European Respiratory Society eBooks · doi:10.1183/2312508x.10004715 · Cited by 1
Can TERT rs2853669 polymorphysm indicate fibrosis in sarcoidosis?
Kement, S., Uğurtay, E. T., Sayit, A. T., Tascı, P., & Ünsal, M. (2023) · Sarcoidosis vasculitis and diffuse lung diseases · doi:10.36141/svdld.v40i4.14023 · Cited by 2
“The human telomerase enzyme has two components: a reverse transcriptase protein component (hTERT), which is the catalytic unit, and a functional RNA component (hTR) that forms a template for nucleotide insertion (1, 5, 6).”
BackgroundEpidemiology and Risk Factors For Interstitial Lung Diseases
(2024) · Frontiers research topics · doi:10.3389/978-2-8325-4644-4 · Cited by 1
Syndromic genetic causes of pulmonary fibrosis
Borie, R., Ba, I., Debray, M., Kannengiesser, C., & Crestani, B. (2024) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000001088 · Cited by 1
All in the Family: Role for Precision Medicine in Screening and Disease Course Prediction
Pearmain, L., Callum, J., Stanel, S. C., & Rivera‐Ortega, P. (2025) · Respiratory medicine · doi:10.1007/978-3-031-87183-2_2 · Cited by 1
Detailed assessment of rare and common TERT variation in a family with a telomere biology disorder
Zeigler, L. P., Flórez-Vargas, O., Altintas, B., Niewisch, M. R., Zhou, W., Giri, N., Rafati, M., Poeschla, M., Sankaran, V. G., Lai, T., et al. (2025) · Human Genetics and Genomics Advances · doi:10.1016/j.xhgg.2025.100536 · Cited by 1
Review of the British Thoracic Society Winter Meeting 2013, 4–6 December, London, UK
Chalmers, J. D., Greening, N. J., José, R. J. P., & Janes, S. M. (2014) · Thorax · doi:10.1136/thoraxjnl-2014-205177 · Cited by 2
Overview of Idiopathic Pulmonary Fibrosis
Nathan, S. D., Brown, A. W., & King, C. S. (2016) · Springer eBooks · doi:10.1007/978-3-319-32794-5_1 · Cited by 1
Genetic Determinants of Interstitial Lung Diseases
Mathai, S. K., Schwartz, D. A., & Borie, R. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-812532-8.00015-x · Cited by 1
Genetics of Idiopathic Pulmonary Fibrosis
Mathai, S. K., & Schwartz, D. A. (2020) · Respiratory medicine · doi:10.1007/978-3-030-31507-8_6 · Cited by 1
Rare Diffuse Lung Diseases of Genetic Origin
Spagnolo, P. (2014) · Springer eBooks · doi:10.1007/978-1-4471-2401-6_36 · Cited by 1
COPD as a Disease of Premature Aging
Boyer, L., Boczkowski, J., & Adnot, S. (2014) · Wiley eBooks · doi:10.1002/9781118396292.ch13
Duffield, J. S. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800102-8.00023-0
Familial interstitial lung disease and new insights on molecular biology and pathogenesis
Beasley, M. B. (2013) · Diagnostic histopathology · doi:10.1016/j.mpdhp.2013.06.010
Aspects génétiques des pneumopathies interstitielles diffuses
Uzunhan, Y. (2012) · Revue des Maladies Respiratoires Actualités · doi:10.1016/s1877-1203(12)70271-9 · Cited by 2
Byrne, R. (2015) · Memorial University Research Repository (Memorial University)
3e Journée française de la fibrose pulmonaire idiopathique. 19 septembre 2014
Cottin, V., Crestani, B., Danel, C. J., Debray, M., Nunès, H., Poletti, V. E., Prévost, G., Vergnon, J.-M., Wallaert, B., & Cordier, J. F. (2015) · Revue de Pneumologie Clinique · doi:10.1016/j.pneumo.2015.06.002
Aging Lung, Environmental and Genetic Factors — Race, Ethnicity and Gender
Keyt, H., Levine, S. M., & Saux, C. J. L. (2015) · WORLD SCIENTIFIC eBooks · doi:10.1142/9789814635011_0003
Cooper, J. N., & Young, N. S. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804152-9.00015-4
Genetic susceptibility to familial interstitial pneumonia and idiopathic pulmonary fibrosis
Mihalek, A. D., Hunninghake, G. M., & Rosas, I. O. (2015) · doi:10.2217/fmeb2013.14.97
Pancytopaenia and breathlessness: Hickam’s Dictum prevails!
Creamer, A. W., Protheroe, R. E., Gunawardena, H., & Barratt, S. L. (2018) · Thorax · doi:10.1136/thoraxjnl-2018-212088
Kwiatkowska, S. (2018) · Advances in respiratory medicine · doi:10.5603/arm.58535
Aspectos clínicos e genéticos de pacientes brasileiros com Pneumonia Intersticial Familiar
Hortense, A. B. (2018) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.17.2018.tde-13092018-084314
Fibrose pulmonaire idiopathique : progrès étiologiques, diagnostiques, et thérapeutiques
Cordier, J.-F. (2014) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/s0001-4079(19)31230-0 · Cited by 1
Telomere-Related Gene Mutations and Lung Diseases: Pulmonary Fibrosis, Emphysema and Lung Cancer
Sastre, L., Molina‐Molina, M., & Perona, R. (2026) · Barcelona Respiratory Network · doi:10.23866/brnrev:2018-0010 · Cited by 2
The lung in liver disease: hepatopulmonary syndrome and portopulmonary hypertension
Torrisi, S. E., Fuhrmann, V., Skowasch, D., & Kreuter, M. (2019) · European Respiratory Society eBooks · doi:10.1183/2312508x.10015119
Telomere syndrome and the lung
Borie, R., Kannengiesser, C., & Crestani, B. (2019) · European Respiratory Society eBooks · doi:10.1183/2312508x.10015719
Telomeropathies - A Genetic Conglomerate
Kaur, G., mishra, P., Tripathi, P., Tyagi, S., Pati, H., & Manapara, M. (2021) · Acta Scientific Cancer Biology · doi:10.31080/ascb.2021.04.0295
Luppi, F., Kalluri, M., Faverio, P., Kreuter, M., & Ferrara, G. (2021) · Kompass Pneumologie · doi:10.1159/000518426
Review of the British Thoracic Society Winter Meeting 2016, 7–9 December, London, UK
Woodcock, H. V., José, R. J. P., & Jenkins, G. R. (2017) · Thorax · doi:10.1136/thoraxjnl-2017-210154 · Cited by 1
Sandbo, N. K. (2018) · Respiratory medicine · doi:10.1007/978-3-319-99975-3_7
Rider, N. L. (2020) · Springer eBooks · doi:10.1007/978-1-4614-9209-2_208-1
Rider, N. L. (2020) · Springer eBooks · doi:10.1007/978-1-4614-8678-7_207
Rider, N. L. (2020) · Springer eBooks · doi:10.1007/978-1-4614-9209-2_207-1
Rider, N. L. (2020) · Springer eBooks · doi:10.1007/978-1-4614-8678-7_208
Lee, K. S., Han, J., Chung, M. P., & Jeong, Y. J. (2013) · Radiology illustrated · doi:10.1007/978-3-642-37096-0_17
Network medicine approaches to diagnostics and therapeutics
Ameli, A. (2020) · Digital Repository Service (Northeastern University) · doi:10.17760/d20383703
Rare Diffuse Lung Diseases of Genetic Origin
Spagnolo, P., & Bernardinello, N. (2023) · Springer eBooks · doi:10.1007/978-3-031-12950-6_28
Genetic and Familial Pulmonary Fibrosis Related to Monogenic Diseases
Borie, R., Kannengiesser, C., & Crestani, B. (2023) · Springer eBooks · doi:10.1007/978-3-031-12950-6_24
Lee, K. S., Han, J., Chung, M. P., & Jeong, Y. J. (2023) · Radiology illustrated · doi:10.1007/978-981-99-6633-2_17
Kannengiesser, C., & Revy, P. (2024) · Wiley eBooks · doi:10.1002/9781394300808.ch12
Campisi, M., Cannella, L., Liviero, F., Tamiazzo, F., Balestro, E., Spagnolo, P., & Pavanello, S. (2026) · npj Aging · doi:10.1038/s41514-026-00434-1
Wang, P., & Xu, Z. (2021) · Figshare · doi:10.6084/m9.figshare.16570235
Cancer risk in patients with pulmonary fibrosis and a rare telomere related gene variant
van der Vis, J. J., Maus, M. T. K., de Bie, C. I., van der Smagt, J. J., Daenen, L. G. M., van Oosterhout, M. F. M., Grutters, J. C., & van Moorsel, C. H. M. (2026) · Respiratory Research · doi:10.1186/s12931-025-03469-2
“Studies on cancer incidence in TBD have primarily focused on early-onset TBDs, such as DC and TBD-BMF, or included mixed TBD phenotypes [18, 24–26], while studies investigating older TBD patients with PF lack comparisons with the general population [11, 15, 27, 28].”
InfluentialOtoshi, R., Kitamura, H., Niwa, T., Murohashi, K., Oda, T., Baba, T., Hagiwara, E., Iwasawa, T., Takemura, T., Okudela, K., et al. (2026) · ERJ Open Research · doi:10.1183/23120541.01619-2025
“Telomere length was measured using quantitative polymerase chain reaction (qPCR) assays and reported as the telomere-to-single-copy gene (T/S) ratio, as previously described [11, 14, 17].”
Glass, J., Groarke, E. M., & Young, N. S. (2026) · Springer eBooks · doi:10.1007/978-3-032-02386-5_17
Rôle de la voie hedgehog dans la fibrose pulmonaire idiopathique
Moshai, E. F. (2013) · theses.fr (ABES) · doi:10.70675/b550340ez33a1z43b7zb4eez8c2cfde874df
Tiendrébéogo, A. J. F. (2016) · theses.fr (ABES) · doi:10.70675/97c14c70z70b4z4788z8c7bzd0fb438c5895
Ruiz‐Pozo, V. A., Cadena-Ullauri, S., Tamayo‐Trujillo, R., Guevara‐Ramírez, P., Paz‐Cruz, E., Cabrera‐Andrade, A., & Zambrano, A. K. (2026) · Biomedicines · doi:10.3390/biomedicines14061211
“In this regard, early studies identified variants in the core telomerase genes TERT and TERC as determinants of leukocyte telomere length (LTL) [3,69,110–117].”
Otoshi, R., Kitamura, H., Oda, T., Kanzawa, A., Okamura, K., Niwa, T., Baba, T., Iwasawa, T., Takemura, T., Mizuguchi, K., et al. (2026) · Respiratory Research · doi:10.1186/s12931-026-03780-6
“Leukocyte telomere length was measured using quantitative polymerase chain reaction (qPCR) and expressed as the telomere-to-single-copy gene (T/S) ratio, as previously described [16, 21, 22].”
Nguyen‐Dang, N., Tran‐Le, Q., Nguyen-Dang, K., Duong‐Minh, N., Nguyen‐Ho, L., & Le-Thuong, V. (2026) · Therapeutic Advances in Respiratory Disease · doi:10.1177/17534666261475563
Bowden, R., Morris-Rosendahl, D. J., Hanson, H., Stanel, S. C., Gibbons, M. A., Renzoni, E. A., Chua, F., Blaikley, J., Parfrey, H., Hirani, N., et al. (2026) · Thorax · doi:10.1136/thorax-2026-225625
Philippot, Q., Crestani, B., Ba, I., Morel, H., de Fontbrune, F. S., Plessier, A., Lainey, É., Kannengiesser, C., & Borie, R. (2026) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2026.09.017
Cellular Senescence and Premature Aging in Lung Diseases
Aoshiba, K., Tsuji, T., Yamaguchi, K., Itoh, M., & Nakamura, H. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-397803-5.00017-4
Metadata
- Authors
- Diaz de Leon, A., Cronkhite, J. T., Katzenstein, A.-L. A., Godwin, J. D., Raghu, G., Glazer, C. S., Rosenblatt, R. L., Girod, C. E., Garrity, E. R., Xing, C., & Garcia, C. K.
- Affiliations
- The University of Texas Southwestern Medical Center (US)
- SUNY Upstate Medical University (US)
- University of Washington Medical Center (US)
- University of Chicago (US)
- Corresponding author
- Garcia, Christine Kim
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2010-05-19
- Volume
- 5
- Issue
- 5
- Pages
- e10680
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC2873288
- OpenAlex
- W2035774221
- Cited by
- 377
- References
- 35
- Citations by year
- 2026: 13 · 2025: 18 · 2024: 22 · 2023: 22 · 2022: 27 · 2021: 24 · 2020: 24 · 2019: 27 · 2018: 34 · 2017: 23 · 2016: 22 · 2015: 23 · 2014: 24 · 2013: 31 · 2012: 25
- FWCI
- 16.01
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Knowledge@UChicago (University of Chicago) (submittedVersion, cc-by-nc-nd)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- Doris Duke Charitable Foundation
- American Heart Association
- National Institutes of Health
- National Heart, Lung, and Blood Institute (R01HL093096)
- National Center for Research Resources (K23RR020632)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Occupational and environmental lung diseases
- Keywords
- telomere length, idiopathic pulmonary fibrosis, TERT mutation, telomerase, telomeropathies, epigenetic inheritance, usual interstitial pneumonia, cigarette smoking, dyskeratosis congenita, germline mutations, age-dependent phenotype, survival
- MeSH terms
- Adult, Aged, Aged, 80 and over, Family, Female, Heterozygote, Humans, Male, Middle Aged, Mutation, Pedigree, Phenotype, Pulmonary Fibrosis, Radiography, Respiratory Function Tests, Smoking, Telomere, Telomerase, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.